Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:35 AM
Ignite Modification Date:
2025-12-25 @ 2:35 AM
NCT ID:
NCT04454034
Eligibility Criteria:
Inclusion Criteria:
* The patients who fulfilled the 1987 ACR（American College of Rheumatology) or 2010 ACR/EULAR（European League Against Rheumatism） RA classification criteria.
* The age is more than 18 years old and less than 60 years old.
* They received stable traditional DMARDs (including Chrysopidae, leflunomide, sulfasalazine, hydroxychloroquine, eilamod) or biological dmrads (including tumor necrosis factor antagonists, IL(Interleukin)-6 receptor antagonists, CD20 monoclonal antibodies) for at least 6 months.
* The disease is still in the active stage, which means the disease activity score (DAS28) is more than 3.2, and the elbow joint function is obviously limited.
* The patient agreed to undergo arthroscopic synovectomy.
* No contraindications were found.
Exclusion Criteria:
* The disease is in remission.
* The patient has contraindications.
* Arthroscopic synovectomy was performed in different patients.
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT04454034
Study Brief:
Protocol Section:
NCT04454034